Inspra (IN-sprah, eplerenone) is now approved for mild to moderate hypertension...not just heart failure

August 2014

Inspra (IN-sprah, eplerenone) is now approved for mild to moderate hypertension...not just heart failure.

Think of it as an alternative to spironolactone.

These aldosterone antagonists are usually added if other BP meds aren't enough to control blood pressure...or aren't appropriate.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

CMRs more emphasis on providing medication reviews
Measles push for measles vaccination due to recent outbreaks
Hypertension Inspra (IN-sprah, eplerenone) is now approved for mild to moderate hypertension...not just heart failure
Pediatrics safety of systemic quinolones in KIDS
Benzodiazepines new efforts to wean patients off benzodiazepines
Neurology & Pain what they can do for mild cognitive impairment
STIs Veregen (VER-ah-jen, sinecatechins) ointment as a new therapy for genital warts
Sleep Disorders continuous positive airway pressure (CPAP) for obstructive sleep apnea
Infectious Diseases More ORAL antibiotics will be used for bone or joint infections
Fungal Infections Jublia (JOO-blee-uh, efinaconazole 10%), a new Rx TOPICAL treatment for fungal nails
Practice We're seeing reports of meds and other products catching fire
Dermatology New guidelines will improve treatment of skin infections, including methicillin-resistant Staph aureus (MRSA)